# RIFADIN
> **NDA050627** · New Drug Application · Sponsor: SANOFI AVENTIS US · Approved 1989-05-25
## Drug
- **FDA Application Number:** NDA050627
- **Application type:** New Drug Application
- **Brand name:** RIFADIN
- **Generic name:** RIFAMPIN
- **Active ingredients:** RIFAMPIN
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** SANOFI AVENTIS US
- **Manufacturer:** Sanofi-Aventis U.S. LLC
- **First approval:** 1989-05-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050627)
---
*AI Analytics · CC0 1.0*